Introduction To Machine To Machine Market

Introduction To M2M Market :

Machine to machine (M2M) uses a devices such as a sensors or meters to capture an event such as temperature, inventory level, that is received and passed through a network such as wireless, wired or hybrid to a software program that translates the captured event into meaningful information.

In product restocking, for example, when a particular item is running low a vending machine can message the distributor. M2M communication is an important aspect of warehouse management, logistic services, supply chain management, fleet management and telemedicine,remote control, robotics, traffic control.  It forms the basis for a concept known as the Internet of Things.

Key components of an M2M system include sensors, RFID, a Wi-Fi or cellular communications link and autonomic computing software programmed to help a networked device interpret data and make decisions. The most well-known type of M2M communication is telemetry, which has been used since the early part of the last century to transmit operational data. Pioneers in telemetrics first used telephone lines -- and later, on radio waves -- to transmit performance measurements gathered from monitoring instruments in remote locations. The Internet and improved standards for wireless technology have expanded the role of telemetry from pure science, engineering and manufacturing to everyday use in products like home heating units, electric meters and Internet-connected appliances. Products built with M2M communication capabilities are often marketed to end users as being “smart.”

Currently, M2M does not have a standardized connected device platform and many M2M systems are built to be task- or device-specific. It is expected that as M2M becomes more pervasive, vendors will need to agree upon standards for device-to-device communications.

 

Market Of M2M Industry :

The global Machine To Machine market is expected to grow from $21.52 billion in 2011 to $85.96 billion in 2017 at a CAGR of 26.1% from 2012 to 2017.

Source :  Markets And Markets

The industry players present along the value chain are involved in initiatives such as alliances, partnerships, and joint ventures to achieve better market recognition and facilitate mobile operators to work directly with companies selling Machine to machine services. Some of the key players involved in the design, development, and supply of M2M solutions include Sierra Wireless (U.S.), Jasper Wireless (U.S.), Telit Communications (Italy), Numerex Corp (U.S.), NTT DoCoMo (Japan), and more.

FOR More Details : Click Here

Introduction to Anesthesia And Anesthesia Drugs Market by 2015

History of Anesthesia :

• William Morton, dentist – first demonstration of successful surgical anesthesia with ether 1846.
• John C. Warren, surgeon at MGH says “Gentlemen, this is no humbug!” – birth of modern anesthesia.
• Dr. John Snow administers chloroform to Queen Victoria (1853)– popularizes anesthesia for childbirth in UK.
• He becomes the first anesthesia specialist.

Note that ether became anesthesia of choice in US, chloroform in UK.

Introduction To Anesthesia :

• Allow surgical, obstetrical and diagnostic procedures to be performed in a manner which is painless to the patient
• Allow control of factors such as physiologic functions and patient movement

 What is “Anesthesia" ...? 

• No universally accepted definition
    
• Usually thought to consist of:
                  1.Oblivion
                  2.Amnesia
                  3.Analgesia
                  4.Lack of Movement
                  5.Hemodynamic Stability
   
• Sensory
  • Absence of intraoperative pain
   
• Cognitive:
  • Absence of intraoperative awareness
  • Absence of recall of intraoperative events

• Motor:
  • Absence of movement
  • Adequate muscular relaxation
   
• Autonomic:
  • Absence of hydrodynamic response 
  • Absence of tearing, flushing, sweating

Anesthetic Techniques :

• General anesthesia
• Regional anesthesia
• Local anesthesia
• Conscious Sedation (monitored anesthesia care)

Goals of General Anesthesia :

• Hypnosis (unconsciousness)
• Amnesia
• Analgesia
• Immobility/decreased muscle tone (relaxation of skeletal muscle)
• Inhibition of nociceptive reflexes
• Reduction of certain autonomic reflexes (gag reflex, tachycardia, vasoconstriction)

Steps of Anesthesia :

1. Induction : The period of time from the onset of administration of the anesthetic to    the development of effective surgical anesthesia in the patient.
2. Maintenance : A sustained surgical anesthesia
3. Recovery : Time from discontinuation of administration of the anesthesia until consciousness and protective physiologic reflexes are regained.

Desired Effects Of General Anesthesia  (Balanced Anesthesia) :

• Rapid induction 
• Sleep
• Analgesia
• Secretion control
• Muscle relaxation 
• Rapid reversal

Anesthesia Drugs Market :

The anesthesia drugs market research specially focuses on ketamine market in U.S.A. Under general anesthesia drugs category, drugs such as propofol, midazolam & diazepam, fospropofol dis odium, sodium pentothal, ketamine, methohexital sodium, pentobarbital, etomidate and fentanyl are studied. The U.S. general anesthesia market was valued at $2 billion in 2011 and is poised to grow at a CAGR of approximately 4% to reach $2.3 billion by 2015.

Intravenous anesthetic drugs accounted for the largest share –65% – of the U.S. general anesthetics drugs market in 2011.

Major players such as Abbott laboratories (U.S.), Astrazeneca Plc. (U.K.), Baxter International Inc. (U.S.), Bedford Laboratories (U.S.), Bioniche Pharmaceuticals (U.S.), Eisai Co. Ltd. (Japan), Hospira Inc. (U.S.) and JHP Pharmaceuticals (U.S.).

For Detail Report : Click Here

Anesthesia Industry In Near Future

History of Anesthesia :

• William Morton, dentist – first demonstration of successful surgical anesthesia with ether 1846.
• John C. Warren, surgeon at MGH says “Gentlemen, this is no humbug!” – birth of modern anesthesia.
• Dr. John Snow administers chloroform to Queen Victoria (1853)– popularizes anesthesia for childbirth in UK.
• He becomes the first anesthesia specialist.

Note that ether became anesthesia of choice in US, chloroform in UK.

Introduction To Anesthesia :

• Allow surgical, obstetrical and diagnostic procedures to be performed in a manner which is painless to the patient
• Allow control of factors such as physiologic functions and patient movement

 What is “Anesthesia" ...? 

• No universally accepted definition
    
• Usually thought to consist of:
                  1.Oblivion
                  2.Amnesia
                  3.Analgesia
                  4.Lack of Movement
                  5.Hemodynamic Stability
   
• Sensory
  • Absence of intraoperative pain
   
• Cognitive:
  • Absence of intraoperative awareness
  • Absence of recall of intraoperative events

• Motor:
  • Absence of movement
  • Adequate muscular relaxation
   
• Autonomic:
  • Absence of hydrodynamic response 
  • Absence of tearing, flushing, sweating

Anesthetic Techniques :

• General anesthesia
• Regional anesthesia
• Local anesthesia
• Conscious Sedation (monitored anesthesia care)

Goals of General Anesthesia :

• Hypnosis (unconsciousness)
• Amnesia
• Analgesia
• Immobility/decreased muscle tone (relaxation of skeletal muscle)
• Inhibition of nociceptive reflexes
• Reduction of certain autonomic reflexes (gag reflex, tachycardia, vasoconstriction)

Steps of Anesthesia :

1. Induction : The period of time from the onset of administration of the anesthetic to    the development of effective surgical anesthesia in the patient.
2. Maintenance : A sustained surgical anesthesia
3. Recovery : Time from discontinuation of administration of the anesthesia until consciousness and protective physiologic reflexes are regained.

Desired Effects Of General Anesthesia  (Balanced Anesthesia) :

• Rapid induction 
• Sleep
• Analgesia
• Secretion control
• Muscle relaxation 
• Rapid reversal

Anesthesia Drugs Market :

The anesthesia drugs market research specially focuses on ketamine market in U.S.A. Under general anesthesia drugs category, drugs such as propofol, midazolam & diazepam, fospropofol dis odium, sodium pentothal, ketamine, methohexital sodium, pentobarbital, etomidate and fentanyl are studied. The U.S. general anesthesia market was valued at $2 billion in 2011 and is poised to grow at a CAGR of approximately 4% to reach $2.3 billion by 2015.

Intravenous anesthetic drugs accounted for the largest share –65% – of the U.S. general anesthetics drugs market in 2011.

Major players such as Abbott laboratories (U.S.), Astrazeneca Plc. (U.K.), Baxter International Inc. (U.S.), Bedford Laboratories (U.S.), Bioniche Pharmaceuticals (U.S.), Eisai Co. Ltd. (Japan), Hospira Inc. (U.S.) and JHP Pharmaceuticals (U.S.).

For Detail Report : CLICK HERE

Commercial Airport Lighting Market - Terminal, Airside and Landside from 2013 To 2018

 

Introduction :

The scope of Airport Lighting Market report is to identify the business opportunity that arises from new airports, terminals or any airport expansion/up gradation. The airfield lighting plays a crucial role at airports in order to enhance passenger experience. Airports have begun to install light emitting diodes (LEDs) on runway edge lights and taxiway lights, in hope to increase safety and to reduce the cost of runway operation.

 

An Airfield Lighting Market has three important divisions:

• Majority of lighting solutions are present at Air side.
• Followed by lighting solutions in the land side right from arrival of passengers to airport and right from disembarkation of passengers to exiting the airport.
•  Lastly, the ground access areas that is parking pick up and drop points and so on.

Lighting is an important safety feature which is necessary at every airport to facilitate night flying. In general, the type of aircraft used in the airport, determines the type of lighting solutions necessary. One particular type of required lighting system is an edge-light system which is used to outline usable operating areas of airports during periods of darkness or low visibility. There are several edge-light systems that are currently available.

Among the key landing and ground-movement visual aids are those located in the pavement of runways and taxiways. These lighted aids can be needed for landing, roll-out, take-off, ground movement, traffic control and high-speed exits from runways and apron guidance for docking. Techniques can be constantly developed to make its installation compatible with paving requirements yet without compromising the integrity and function of the lights.

The latest Airport Lighting said to be very advanced and effective solution/systems for air side, land side and ground access. Many designs and modules have been developed by many consultants and the airport has the option to choose which module they can use for their airports.

 

Market Of  Airport Lighting :

 

Markets Covered : 

Airport Lighting Market segments the airport lighting market by:

1. North America,
2. South America,
3. Europe (including Russia),
4. Africa and
5. APAC

 

Stakeholders Of Airport Lighting Market :

1. Light manufacturers
2. Hardware/service and solutions providers
3. Airlines
4. Technology suppliers
5. Airport Lighting consultants
6. Aviation regulating bodies
7.  Airports
8. Passengers  

 Airport Lighting accounts for approximately 25% to 30% of electrical use in most commercial buildings. At airports, this can increase up to 40%. With the addition of Operation and Maintenance, lighting holds the greatest prospective for saving energy at small airport terminals. Retrofits in lighting systems can have significant impact on the other, more costly infrastructure upgrades such as ventilation and boilers equipment owing to reduction in cooling loads provided by more efficient fluorescent fixtures. Lighting upgrades open up power for other systems or expansion of facilities. Airport Lighting improvements, coupled with other energy efficiency projects, eliminated the need to construct a new energy plant. Airport Lighting upgrades also has the potential to improve productivity and passenger experience by improving light quality and levels, improves more control by turning lights off or balancing levels with daylight, and reduce maintenance costs by increasing lamp life.

Lamp Fixtures

Extensive research says that the lamp and fixture retrofits as low-cost energy efficiency improvements that return noteworthy savings. It may also be noted that lighting improvements are one of the most noticeable ways to save energy, which, along with visual display upgrades. Screw-in incandescent fixtures to compact fluorescent lamps (CFL) are some of the change that is happening all over the world, which use up to 75% less energy and last significantly longer. The cost of CFL fixtures has dropped extensively in recent years making this upgrade even more affordable. Maintenance savings may also be found owing to reduced replacement frequency.

Although often distinguished as a high-efficiency lamp, fluorescents can be limited in lighting output comparative to other lamps, specifically high-intensity-discharge or HID. Areas where conversion from fluorescent to HID may be appropriate include exterior precautionary lighting on terminals and areas which can be surrounded by parking structures attached to the terminals.

Central Automated Lighting

Another type of lighting control system involves centralized control of all lighting fixtures within the terminal. By using central control, areas of activity that were not previously monitored and tracked will now be monitored and tracked, and ignored or crisis areas will be identified. In addition, some central controls can track total hours that lamps have been in service, supplying staff on duty with useful information with which they could schedule re-lamping programs. Another strategy that put forth is to plan lighting controls to periodical turning off the lights within a certain area of the building during the off-peak period. Lighting reduction during non-peak hours and utilization of central lighting control is a common practice followed by most of the airports.

According to a new market research report, "Commercial Airport Lighting Market (Terminal, Airside & Landside)(2013 – 2018)", authored by MarketsandMarkets , the total airport lighting market is expected to reach $244.3 Million by 2018 with a CAGR of 6.07%. 

For Detail Report : http://www.marketsandmarkets.com/Market-Reports/airport-lighting-market-1060.html

 

Molecular Diagnostics Market : Trends , Opportunities and Market Forecasts

Introduction :

Molecular diagnostic detects a specific sequence in DNA or RNA that may be associated with disease,also includes SNP,insertions,deletions,rearrangements and others.

 

 Application can be Found in Following Areas:

1. Infectious diseases
2. Oncology
3. Pharmacogenomics
4. Genetic disease screening
5. Human leukocyte antigen typing
6. Coagulation

 

In Molecular Diagnostic each molecule requires following three steps :

1. The extraction and purification of nucleic acid.
2. The amplification or making copies of the nucleic acid of interest (target) or attaching multiple copies of a dye to a   single target copy.
3. The detection of the amplified target using real time polymerase chain reaction (PCR) or end product detection including   microarrays, Luminex (similar to flow cytometry), or sequencing.

These three steps can be performed by three separate devices or combined into one device .

 

The Primary goal of Molecular Diagnostics :

• To introduce essential concepts in  molecular diagnostics that impact on the identification of novel markers of human diseases

• To develop and apply useful molecular assays to monitor disease, determine appropriate treatment strategies, and predict disease outcomes.

Following Image Demonstrate Molecular Diagnostics :

 Source : http://www.cancer.gov

Molecular Diagnostics Market  

Molecular diagnostics (MDx) is a new class of diagnostic tests that identify nucleic acids or proteins to test the status of a disease. These nucleic acids or proteins, which belong to individual patients or foreign organisms, help determine a specific therapy, or risk of developing a specific disease, or other health conditions. MDx is the fastest growing segment within the in-vitro diagnostic (IVD) space, driven by accuracy, high sensitivity, fast turnaround time, easy workflow, and cost-effective testing.

Owing to these factors, The molecular diagnostics market crossed $4.8 billion in 2011, and is poised to grow at a CAGR of 9.1% in the next five years.

MDx involves instruments and reagents that leverage multiple technologies to identify genetic variations. The technologies utilized in molecular diagnostics include polymerase chain reaction (PCR), transcription mediated amplification (TMA), hybridization (In-situ Hybridization & fluorescence in situ hybridization (FISH)), DNA Sequencing, next generation sequencing (NGS), micro arrays, and others.

Molecular diagnostics has applications in infectious disease molecular testing, oncology, blood screening, genetic testing, DNA fingerprinting (e.g., paternity testing, forensic testing), microbiology, tissue typing, and food pathogen detection testing. The booming MDx areas are molecular tests for women’s health, oncology, and organ transplant testing.

Global Molecular Diagnostics Market Revenue, By Technology, 2010 - 2017 ($Million)

Source : http://www.marketsandmarkets.com

North America dominated the molecular diagnostics market in 2011; the U.S. is the prime market for molecular diagnostics companies due to the availability of government funds, rising incidence of chronic diseases related to the aging population, and high awareness of pharmacogenomics/personalized medicine. In addition, major local companies have easy access to this market, which makes the U.S. the largest and most significant market for suppliers. Europe is still suffering from the economic downturn and the Eurozone crisis and it is predicted that customers will delay purchases of capital equipments; this is expected to hamper the growth of this market, albeit for a short term. The Asian market, however, shows greater opportunities with the highest CAGR due to increased purchasing power, an emerging mindset toward wellness, preventive medicine, and increased access to cutting-edge products and services.

Factors like increase in awareness and acceptance of personalized medicine, advancements in molecular techniques, and increasing investments in genomics & proteomics research will spur the molecular diagnostics market in the future. Yet, reimbursement issues for non-coded tests and complex regulatory framework will restrict the growth of this market.

Molecular diagnostic tools have a vast base of end-users, which includes hospital-based laboratories, reference laboratories, and others (physicians’ labs, research laboratories, other healthcare clinics, and government agencies). Hospitals offer the major chunk of business for MDx companies; however, reference laboratories are growing at a high CAGR and are driving the market, as they perform complex tests and offer expertise to small hospitals setups, clinical researchers, and insurance companies.

Although the market for molecular diagnostics is fragmented with more than 500 companies, the most prominent players are Roche Diagnostics (Switzerland), Novartis (Switzerland), Gen-Probe (U.S.), Qiagen (The Netherlands), Abbott Diagnostics (U.S.), Becton Dickinson (U.S.) and Cepheid (U.S.), to name a few.

For Complete Market Research Report On Molecular Diagnostics Market : http://www.marketsandmarkets.com/Market-Reports/molecular-diagnostic-market-833.html